Moderna Seeks to Dismiss Covid-19 Vaccine Patent Lawsuit
Moderna Inc. is trying to fend off rival companies’ claims that its Covid-19 vaccine infringes their patents, arguing that the companies may only pursue their claims seeking royalties from the federal government. Moderna on Friday filed a motion to dismiss some of the patent-infringement claims in the lawsuit, which was filed in February by two small biotechnology companies, Arbutus Biopharma Corp. and Genevant Sciences GmbH, in federal court in Delaware. It is the latest move in the high-stakes legal battles that are breaking out among companies and the government over patents surrounding Covid-19 vaccines. Arbutus and Genevant claimed in their lawsuit that Moderna’s vaccine has components covered by their patents, and they are seeking royalties from the multibillion-dollar sales of Moderna’s vaccine.
The Wall Street Journal - May 7, 2022View the full story here: https://www.wsj.com/articles/moderna-seeks-to-dismiss-covid-19-vaccine-patent-lawsuit-11651871569